BSE Live
Dec 09, 16:01Prev. Close
327.05
Open Price
326.55
Bid Price (Qty.)
327.80 (2)
Offer Price (Qty.)
342.00 (345)
NSE Live
Dec 09, 15:31Prev. Close
326.80
Open Price
325.00
Bid Price (Qty.)
337.25 (144)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -171.22 | 46.23 | -66.14 | -51.88 | -18.93 | |
| Net CashFlow From Operating Activities | -30.47 | 104.88 | 118.02 | 130.67 | 90.69 | |
| Net Cash Used In Investing Activities | -34.76 | -5.35 | 55.29 | -25.83 | 16.44 | |
| Net Cash Used From Financing Activities | 90.74 | -101.14 | -164.35 | -106.96 | -117.38 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 25.51 | -1.61 | 8.97 | -2.13 | -10.25 | |
| Cash And Cash Equivalents Begin of Year | 14.71 | 16.08 | 7.47 | 9.59 | 19.99 | |
| Cash And Cash Equivalents End Of Year | 40.22 | 14.47 | 16.44 | 7.47 | 9.74 |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y